跳至主要内容
临床试验/NCT01607684
NCT01607684已完成2 期

Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis

Martin-Luther-Universität Halle-Wittenberg2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
2
主要终点
Frequency of gastric peristalsis

研究概览

简要总结

The purpose of this study is to determine whether Magnetic Marker Monitoring is an appropriate opportunity to diagnose and to quantify a suspicious gastroparesis in subjects with diabetic polyneuropathy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 50 years
  • written informed consent
  • Diabetes mellitus (only Diabetes mellitus group)
  • Symptoms of diabetic gastroparesis with respect to nausea, postprandial fullness, abdominal pain, nausea, vomiting, abdominal bloating, early satiety, erratic blood glucose levels and weight loss evaluated by a standardized questionnaire (only Diabetes mellitus group)
  • actually measured HbA1c (only Diabetes mellitus group)

排除标准

  • Subject who is pregnant or breast feeding.
  • Subject unwilling or unable to comply with study requirements.
  • Any investigational agent or participation in another clinical trial within 28 days prior to randomization
  • Any kind of disorder that compromises the ability of the subject to give written informed consent and/or comply with the study procedures.
  • History of any medical condition that may increase the risks associated with study participation or may interfere with the interpretation of the study results.
  • Known allergy to the investigational product, to any of its excipients
  • Active inflammatory bowel disease, serious gastric ulceration or other bowel diseases like e.g. coeliac disease
  • Implanted cardiac cardioverter-defibrillator or cardiac pacemaker
  • Stenosis or stricture of gastrointestinal tract or any surgery in this region except for cholecystectomy or appendectomy
  • Long-term medication with drug, that influence gastrointestinal motility (opiate, opioids, erythromycin, metoclopramide, laxatives) < 3 days before randomisation and before magnetic marker monitoring

结局指标

主要结局

Frequency of gastric peristalsis

时间窗: 4 hours

次要结局

  • Intensity of gastric peristaltic waves(4 hours)
  • Correlation with other parameters of diabetic polyneuropathy (nausea, postprandial fullness, abdominal pain, nausea, vomiting, abdominal bloating, early satiety, erratic blood glucose levels and weight loss evaluated by a standardized questionnaire)(4 hours)
  • Influence of age on parameters of diabetic polyneuropathy measurable by magnetic marker imaging(4 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. med. Thomas Seufferlein

Prof. Dr. med.

Martin-Luther-Universität Halle-Wittenberg

研究点 (2)

Loading locations...

相似试验